Literature DB >> 2864344

Transamination of neutral amino acids and 2-keto acids in pancreatic B-cell mitochondria.

S Lenzen, W Schmidt, U Panten.   

Abstract

High aminotransferase activities catalyzing the reactions between L-glutamate and L-glutamine and the aliphatic ketomonocarboxylic acids 2-ketoisocaproate, 2-ketocaproate, and 2-ketoisovalerate were observed in pancreatic B-cell mitochondria. While maximal rates of transamination with L-glutamate were observed in the presence of micromolar concentrations of keto acid, maximal rates of transamination with L-glutamine were recorded only in the presence of millimolar concentrations of keto acid. The insulin secretagogue 2-ketoisocaproate was the most effective transamination partner for L-glutamate, while the insulin secretagogue 2-ketocaproate was the most effective transamination partner for L-glutamine. Since B-cell mitochondria are well supplied with L-glutamate and L-glutamine, 2-ketoglutarate generation in the presence of these two neutral 2-keto acids may be an important prerequisite for their insulin secretory potency. High rates of transamination of 2-ketoglutarate were observed in the pancreatic B-cell mitochondria with the branched-chain amino acids L-leucine and L-valine, but not with L-norleucine. In connection with the ability of L-leucine to activate glutamate dehydrogenase, this high activity of the branched-chain amino acid aminotransferase in pancreatic B-cell mitochondria may provide an explanation for the insulin secretory potency of this amino acid.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2864344

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

1.  Insulin secretion profiles are modified by overexpression of glutamate dehydrogenase in pancreatic islets.

Authors:  S Carobbio; H Ishihara; S Fernandez-Pascual; C Bartley; R Martin-Del-Rio; P Maechler
Journal:  Diabetologia       Date:  2003-12-20       Impact factor: 10.122

2.  Oxo-4-methylpentanoic acid directs the metabolism of GABA into the Krebs cycle in rat pancreatic islets.

Authors:  Inés Hernández-Fisac; Sergio Fernández-Pascual; Henrik Ortsäter; Javier Pizarro-Delgado; Rafael Martín del Río; Peter Bergsten; Jorge Tamarit-Rodriguez
Journal:  Biochem J       Date:  2006-11-15       Impact factor: 3.857

Review 3.  Alloxan: history and mechanism of action.

Authors:  S Lenzen; U Panten
Journal:  Diabetologia       Date:  1988-06       Impact factor: 10.122

4.  Transamination is required for {alpha}-ketoisocaproate but not leucine to stimulate insulin secretion.

Authors:  Yingsheng Zhou; Thomas L Jetton; Stephanie Goshorn; Christopher J Lynch; Pengxiang She
Journal:  J Biol Chem       Date:  2010-08-24       Impact factor: 5.157

5.  A distinct difference in the metabolic stimulus-response coupling pathways for regulating proinsulin biosynthesis and insulin secretion that lies at the level of a requirement for fatty acyl moieties.

Authors:  R H Skelly; L C Bollheimer; B L Wicksteed; B E Corkey; C J Rhodes
Journal:  Biochem J       Date:  1998-04-15       Impact factor: 3.857

6.  Regulation of energy metabolism in pancreatic islets by glucose and tolbutamide.

Authors:  U Panten; B J Zünkler; S Scheit; K Kirchhoff; S Lenzen
Journal:  Diabetologia       Date:  1986-09       Impact factor: 10.122

7.  Inhibition of aconitase by alloxan and the differential modes of protection of glucose, 3-O-methylglucose, and mannoheptulose.

Authors:  S Lenzen; M Mirzaie-Petri
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1992-11       Impact factor: 3.000

8.  Dual effect of spermine on mitochondrial Ca2+ transport.

Authors:  S Lenzen; W Münster; I Rustenbeck
Journal:  Biochem J       Date:  1992-09-01       Impact factor: 3.857

9.  Effects of lysophosphatidylcholine and arachidonic acid on the regulation of intracellular Ca2+ transport.

Authors:  I Rustenbeck; S Lenzen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989 Jan-Feb       Impact factor: 3.000

10.  Structural requirements of alloxan and ninhydrin for glucokinase inhibition and of glucose for protection against inhibition.

Authors:  S Lenzen; F H Brand; U Panten
Journal:  Br J Pharmacol       Date:  1988-11       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.